News
Pfizer’s alopecia drug gets EU nod, chasing Lilly’s Olumiant
Pfizer has picked up approval in the EU for Litfulo, its JAK inhibitor for severe alopecia areata, extending its challenge to Eli Lilly’s first-to-market Olumiant.
